Treatment of Myelodysplastic syndrome with azacitidine and erythropoietin

被引：0
|
作者：
Limaye, Sewanti [1 ]
Lipshitz, Jay [1 ]
Dulala, Renuka [1 ]
Patel, Dilip [1 ]
机构：
[1] Long Isl Jewish Med Ctr, New Hyde Pk, NY USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4627
引用
收藏
页码：230B / 230B
页数：1
相关论文
共 50 条
  • [31] Outcome of 5-Azacitidine and Decitabine Treatment in Elderly Patients with Myelodysplastic Syndrome
    Nam, Seung-Hyun
    Lim, Taekyu
    Kim, Bong-Seog
    BLOOD, 2012, 120 (21)
  • [32] Poor Outcome of Patients with Myelodysplastic Syndrome (MDS) After Azacitidine Treatment Failure
    Lin, Karen
    Reljic, Tea
    Kumar, Ambuj
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2010, 116 (21) : 1199 - 1200
  • [33] Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome
    Kataoka, Asami
    Mizumoto, Chisaki
    Kanda, Junya
    Iwasaki, Makoto
    Sakurada, Maki
    Oka, Tomomi
    Fujimoto, Masakazu
    Yamamoto, Yosuke
    Yamashita, Kohei
    Nannya, Yasuhito
    Ogawa, Seishi
    Takaori-Kondo, Akifumi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (06) : 919 - 924
  • [34] Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome
    Asami Kataoka
    Chisaki Mizumoto
    Junya Kanda
    Makoto Iwasaki
    Maki Sakurada
    Tomomi Oka
    Masakazu Fujimoto
    Yosuke Yamamoto
    Kohei Yamashita
    Yasuhito Nannya
    Seishi Ogawa
    Akifumi Takaori-Kondo
    International Journal of Hematology, 2023, 117 : 919 - 924
  • [35] Erythropoietin receptor in myelodysplastic syndrome and leukemia
    Takeshita, A
    Shinjo, K
    Naito, K
    Ohnishi, K
    Higuchi, M
    Ohno, R
    LEUKEMIA & LYMPHOMA, 2002, 43 (02) : 261 - 264
  • [36] The role of erythropoietin in the anemia of myelodysplastic syndrome
    Stein, RS
    CLINICAL LYMPHOMA, 2003, 4 : S36 - S40
  • [37] AZACITIDINE IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE ANALYSIS
    Mousinho, F.
    Sousa e Santos, P.
    Viegas, E.
    Madureira, B.
    Gomes, A. P.
    Falcao, F.
    Lima, F.
    LEUKEMIA RESEARCH, 2017, 55 : S74 - S74
  • [38] Azacitidine for the Treatment of Lower Risk Myelodysplastic Syndromes
    Musto, Pellegrino
    Maurillo, Luca
    Spagnoli, Alessandra
    Gozzini, Antonella
    Rivellini, Flavia
    Lunghi, Monia
    Villani, Oreste
    Aloe-Spiriti, Maria Antonietta
    Venditti, Adriano
    Santini, Valeria
    CANCER, 2010, 116 (06) : 1485 - 1494
  • [39] Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Low-risk Myelodysplastic Syndrome by Azacitidine
    Daitoku, Shinya
    Aoyagi, Tomomi
    Takao, Shinichiro
    Tada, Seiya
    Kuroiwa, Mika
    INTERNAL MEDICINE, 2018, 57 (20) : 2995 - 2999
  • [40] Late Hematological Improvement of Myelodysplastic Syndrome Following Treatment with 5-Azacitidine Therapy
    Takaoka, Kensuke
    Hangaishi, Akira
    Ito, Ayumu
    Morioka, Takehiko
    Kida, Michiko
    Usuki, Kensuke
    INTERNAL MEDICINE, 2014, 53 (19) : 2241 - 2243
12345